These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 21547906)
1. Ewing sarcoma cells express RANKL and support osteoclastogenesis. Taylor R; Knowles HJ; Athanasou NA J Pathol; 2011 Oct; 225(2):195-202. PubMed ID: 21547906 [TBL] [Abstract][Full Text] [Related]
2. BSP and RANKL induce osteoclastogenesis and bone resorption synergistically. Valverde P; Tu Q; Chen J J Bone Miner Res; 2005 Sep; 20(9):1669-79. PubMed ID: 16059638 [TBL] [Abstract][Full Text] [Related]
3. Bone stromal cells in pagetic bone and Paget's sarcoma express RANKL and support human osteoclast formation. Sun SG; Lau YS; Itonaga I; Sabokbar A; Athanasou NA J Pathol; 2006 May; 209(1):114-20. PubMed ID: 16482498 [TBL] [Abstract][Full Text] [Related]
4. Cellular and humoral mechanisms of osteoclast formation in Ewing's sarcoma. Lau YS; Adamopoulos IE; Sabokbar A; Giele H; Gibbons CL; Athanasou NA Br J Cancer; 2007 Jun; 96(11):1716-22. PubMed ID: 17533390 [TBL] [Abstract][Full Text] [Related]
5. TRAF2 is essential for TNF-alpha-induced osteoclastogenesis. Kanazawa K; Kudo A J Bone Miner Res; 2005 May; 20(5):840-7. PubMed ID: 15824857 [TBL] [Abstract][Full Text] [Related]
6. RANKL-dependent and RANKL-independent mechanisms of macrophage-osteoclast differentiation in breast cancer. Lau YS; Danks L; Sun SG; Fox S; Sabokbar A; Harris A; Athanasou NA Breast Cancer Res Treat; 2007 Sep; 105(1):7-16. PubMed ID: 17151927 [TBL] [Abstract][Full Text] [Related]
7. T cell activation induces human osteoclast formation via receptor activator of nuclear factor kappaB ligand-dependent and -independent mechanisms. Weitzmann MN; Cenci S; Rifas L; Haug J; Dipersio J; Pacifici R J Bone Miner Res; 2001 Feb; 16(2):328-37. PubMed ID: 11204433 [TBL] [Abstract][Full Text] [Related]
8. Importance of membrane- or matrix-associated forms of M-CSF and RANKL/ODF in osteoclastogenesis supported by SaOS-4/3 cells expressing recombinant PTH/PTHrP receptors. Itoh K; Udagawa N; Matsuzaki K; Takami M; Amano H; Shinki T; Ueno Y; Takahashi N; Suda T J Bone Miner Res; 2000 Sep; 15(9):1766-75. PubMed ID: 10976996 [TBL] [Abstract][Full Text] [Related]
9. Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation. Quinn JM; Horwood NJ; Elliott J; Gillespie MT; Martin TJ J Bone Miner Res; 2000 Aug; 15(8):1459-66. PubMed ID: 10934644 [TBL] [Abstract][Full Text] [Related]
10. Osteoclast formation and function in pigmented villonodular synovitis. Taylor R; Kashima TG; Knowles H; Gibbons CL; Whitwell D; Athanasou NA J Pathol; 2011 Sep; 225(1):151-6. PubMed ID: 21706481 [TBL] [Abstract][Full Text] [Related]
11. Malignant B-lymphoid cells with bone lesions express receptor activator of nuclear factor-kappaB ligand and vascular endothelial growth factor to enhance osteoclastogenesis. Shibata H; Abe M; Hiura K; Wilde J; Moriyama K; Sano T; Kitazoe K; Hashimoto T; Ozaki S; Wakatsuki S; Kido S; Inoue D; Matsumoto T Clin Cancer Res; 2005 Sep; 11(17):6109-15. PubMed ID: 16144909 [TBL] [Abstract][Full Text] [Related]
12. Arthroplasty membrane-derived fibroblasts directly induce osteoclast formation and osteolysis in aseptic loosening. Sabokbar A; Itonaga I; Sun SG; Kudo O; Athanasou NA J Orthop Res; 2005 May; 23(3):511-9. PubMed ID: 15885469 [TBL] [Abstract][Full Text] [Related]
13. Receptor activator of NF-kappaB ligand-stimulated osteoclastogenesis in mouse marrow culture is suppressed by zinc in vitro. Yamaguchi M; Uchiyama S Int J Mol Med; 2004 Jul; 14(1):81-5. PubMed ID: 15202020 [TBL] [Abstract][Full Text] [Related]
14. NMDA glutamate receptors are expressed by osteoclast precursors and involved in the regulation of osteoclastogenesis. Merle B; Itzstein C; Delmas PD; Chenu C J Cell Biochem; 2003 Oct; 90(2):424-36. PubMed ID: 14505357 [TBL] [Abstract][Full Text] [Related]
15. Receptor activator of NF-kappaB ligand induces the expression of carbonic anhydrase II, cathepsin K, and matrix metalloproteinase-9 in osteoclast precursor RAW264.7 cells. Fujisaki K; Tanabe N; Suzuki N; Kawato T; Takeichi O; Tsuzukibashi O; Makimura M; Ito K; Maeno M Life Sci; 2007 Mar; 80(14):1311-8. PubMed ID: 17306833 [TBL] [Abstract][Full Text] [Related]
16. Hypoxia-inducible factor is expressed in giant cell tumour of bone and mediates paracrine effects of hypoxia on monocyte-osteoclast differentiation via induction of VEGF. Knowles HJ; Athanasou NA J Pathol; 2008 May; 215(1):56-66. PubMed ID: 18283716 [TBL] [Abstract][Full Text] [Related]
17. Effect of cytosolic phospholipase A2 on proinflammatory cytokine-induced bone resorptive genes including receptor activator of nuclear factor kappa B ligand in human dental pulp cells. Kim YS; Min KS; Lee HD; Oh HW; Kim EC J Endod; 2010 Apr; 36(4):636-41. PubMed ID: 20307736 [TBL] [Abstract][Full Text] [Related]
18. Two distinct cellular mechanisms of osteoclast formation and bone resorption in periprosthetic osteolysis. Sabokbar A; Kudo O; Athanasou NA J Orthop Res; 2003 Jan; 21(1):73-80. PubMed ID: 12507582 [TBL] [Abstract][Full Text] [Related]
19. Phenotypic and molecular studies of giant-cell tumors of bone and soft tissue. Lau YS; Sabokbar A; Gibbons CL; Giele H; Athanasou N Hum Pathol; 2005 Sep; 36(9):945-54. PubMed ID: 16153456 [TBL] [Abstract][Full Text] [Related]
20. Sesquiterpene lactone parthenolide blocks lipopolysaccharide-induced osteolysis through the suppression of NF-kappaB activity. Yip KH; Zheng MH; Feng HT; Steer JH; Joyce DA; Xu J J Bone Miner Res; 2004 Nov; 19(11):1905-16. PubMed ID: 15476591 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]